Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Scoping of how Whole Genome Sequencing (WGS), other molecular technologies and the management of generated data impact on patient pathways and outcomes in the management of infectious diseases?
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| The Association for Clinical Biochemistry and Laboratory Medicin | - | £19,950 | - |